论文部分内容阅读
本文讨论了二期人工晶体植入术的适应证、手术方法及视力预后。方法：５１例５２只眼行二期人工晶体植入术，２８只眼为后房型人工晶体植入，其中８只眼为人工晶体缝线固定术；２４只眼为前房型人工晶体植入。结果：术后随访６～４２个月，平均１４个月，术后最佳矫正视力≥０．５者３４只眼（６５．４％），术后最佳矫正视力≥术前最佳矫正视力３９只眼（７５％）。并发症为人工晶体倾斜、继发性青光眼、视网膜脱离、前房出血和前房积脓。结论：二期人工晶体植入是安全有效的。新型弹性开放袢一体型前房型人工晶体具有操作简便、术后反应轻、并发症少的优点，是后房型人工晶体二期植入的重要补充
This article discusses the second phase IOL indications, surgical methods and vision prognosis. Methods: Fifty - one 51 eyes underwent second - stage IOL implantation and 28 eyes underwent posterior chamber intraocular lens implantation. Among them, 8 eyes were sutured with artificial suture and 24 eyes were anterior chamber intraocular lens implantation. Results: All the patients were followed up for 6 ~ 42 months (average 14 months), 34 eyes (65.4%) had best corrected visual acuity ≥ 0.5 after operation, best corrected visual acuity 39 eyes (75%). The complications were artificial lens tilt, secondary glaucoma, retinal detachment, hyphema and anterior chamber empyema. Conclusion: Second-stage intraocular lens implantation is safe and effective. The new elastic open 袢 anterior chamber intraocular lens has the advantages of simple operation, light postoperative response, fewer complications, and is an important complement to the second-stage implantation of posterior chamber intraocular lens